Andreas Agathangelidis

8PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyHaematological tumoursLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jan 07, 2026
Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis.

Andreas Agathangelidis, Anastasia Iatrou, Nikolaos Pechlivanis

|Dec 30, 2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1.

Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici

|Jul 29, 2025
Restoration of Autophagy and Apoptosis in Myelodysplastic Syndromes: The Effect of Azacitidine in Disease Pathogenesis.

Georgia Tsekoura, Andreas Agathangelidis, Christina-Nefeli Kontandreopoulou

|Jul 12, 2025
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.

Angeliki Meintani, Mustafa Ozdogan, Nikolaos Touroutoglou

|Sep 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Daniel Hägerstrand, Blaž Oder, Diego Cortese

Pageof 2

Frequent Collaborators

5 joint publications

Paolo Ghia

4 joint publications

Kostas Stamatopoulos

2 joint publications

Angeliki Taliouraki

2 joint publications

Lydia Scarfò